Aizon Raises $20M in Series C Funding to Revolutionize Pharma Manufacturing

      Aizon, the AI SaaS provider transforming pharmaceutical manufacturing, announced today the closing of a $20 million...

February 09, 2024 | Friday | News
Novartis Bolsters Oncology Portfolio with MorphoSys AG Acquisition for EUR 2.7 Billion

The acquisition encompasses key assets such as pelabresib, a promising late-stage BET inhibitor for myelofibrosis (MF), and tulmimetostat, an early-stage i...

February 06, 2024 | Tuesday | News
Wegovy Producer Catalent Snapped Up in $16.5 Billion Deal by Novo Holdings

In a strategic shift that promises to redefine the pharmaceutical industry, Novo Holdings, the investment arm of Novo Nordisk's parent foundation, has unve...

February 05, 2024 | Monday | News
Alto's Brainy Bonanza: Neuroscience Powerhouse ANRO Unleashes $128.6M IPO Surge

In a move that adds an intriguing layer to the IPO dynamics, Alto has granted underwriters a 30-day option to scoop up an additional 1,206,000 shares of co...

February 02, 2024 | Friday | News
Chairman Marc N. Casper Commends Team Effort as Thermo Fisher Scientific Thrives in 2023

“Thanks to the strong contributions from our team, we delivered differentiated performance in 2023 and enabled our customers’ success,” s...

January 31, 2024 | Wednesday | Company results
Carcinotech Secures $5.3M Funding to Boost Global Expansion of Carcino3D Technology

Carcinotech has raised $5.3 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this yea...

January 31, 2024 | Wednesday | News
Novartis CEO Vas Narasimhan Affirms Company's Transformation and Growth Targets: Strong Operational Performance and Ten Positive Phase 3 Readouts Highlight Strategic Success

Novartis, under the leadership of CEO Vas Narasimhan, has announced robust financial results for the full year of 2023. The company reported a 10% growth i...

January 31, 2024 | Wednesday | Company results
Lonza's CEO Albert M. Baehny Steers Company to Stellar Success in 2023, Defying Economic Headwinds with Robust Financial Performance and Ambitious Growth Initiatives

Robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth CORE EBITDA of CHF 2 billion, resulting in a margin of 29.8% Continued growth inves...

January 26, 2024 | Friday | Company results
GDMC, Singaporean Advanced Therapy Manufacturer, Raises $21M to Expand Global Genetic Medicine Operations

The round also included premier investors such as WI Harper Group, a leading cross-border venture capital firm, and SEEDS Capital, the investment arm of go...

January 26, 2024 | Friday | News
Robert B. Ford, CEO of Abbott, Highlights Portfolio Strength and Diversity as Key to 2023 Success and Foresees Continued Growth in 2024 and Beyond.

Fourth-quarter reported sales increased 1.5 percent; organic sales growth for the underlying base business increased 11.0 percent Full-year 2023 reporte...

January 24, 2024 | Wednesday | Company results
DelSiTech Secures EUR 10M Funding to Advance Silica-Based Drug Delivery Platform

New investment from DRW Venture Capital LLC and Tolmar International Ltd Funds will be used to advance its proprietary, silica-based, drug delivery...

January 16, 2024 | Tuesday | News
Pfizer Urges Shareholders to Decline TRC Capital's Below-Market Mini-Tender Offer

Pfizer does not endorse TRC Capital Investment’s unsolicited mini-tender offer and recommends that stockholders do not tender their shares in respons...

January 11, 2024 | Thursday | News
Via Scientific Raises $5M to Boost Life Sciences Discovery

Unlocking the next generation of life sciences innovations will depend on researchers' abilities to not just uncover new data, but to identify patterns at ...

January 10, 2024 | Wednesday | News
QIAGEN Unleashes a Thrilling Windfall: Proposes a Whopping $300 Million Bonanza for Shareholders!

QIAGEN  announced a plan to return up to approximately $300 million (maximum EUR 273 million) to shareholders through a synthetic share repurchase tha...

January 08, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close